Cancer Weekly articles from November 2001

Cancer Weekly archives from November 2001

Similar Efficacy In Stem Cell Graft Induction Regimens With Or Without Radiation.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Preparative regimens for autologous stem cell transplantation produce similar results whether or not radiation therapy is used, according to researchers in the...

Tumor Vaccine Causes Regression, Reduces Metastasis In Incurable Melanoma.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a new vaccine consisting of autologous tumor cells complexed with a hapten, investigators at Thomas Jefferson University's Kimmel Cancer Center have seen...

Acupuncture Is As Effective As Drugs For Pain, Nausea.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Acupuncture is just as effective as the leading medication used to reduce nausea and vomiting after major breast surgery, according to a new study conducted by Duke University Medical Center...

Researchers To Study Why Blacks Get, Die More From Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- The National Cancer Institute has awarded a multimillion dollar grant for a potentially landmark study to determine why African Americans are more likely than other groups to develop cancer and to die...

Researchers Seek To Develop Test For Women's Deadliest Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Marysol Rojas' mission is to teach women to talk with each other about cancer, especially cancer that attacks their ovaries, the deadliest women's cancer. That's why she volunteered for a study at...

Animal-Based Nutrients Linked With Higher Risk Of Stomach, Esophageal Cancers.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Yale School of Medicine researchers have found that a diet high in cholesterol, animal protein and vitamin B12 is linked to risk of a specific type of cancer of the stomach and esophagus that has been...

Gene Vectors Might Be Next Best Thing For Vaccine Studies.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writers - Millions of patients affected by autoimmune illness, cancer, infections, and other diseases could one day be helped by taking gene therapies designed to...

Arsenic Trioxide Produces Strong Remission Rates.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Trisenox (arsenic trioxide) injection demonstrates 63% overall survival at 24 months in the treatment of relapsed or refractory acute promyelocytic leukemia (APL), a severe and life-threatening form of...

Protein Suppresses Cell Growth, Could Be Novel Therapy Candidate.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The gene for a protein that suppresses cell growth and movement may be a prospective new candidate for antiangiogenesis therapy. The cyclin-dependent...

Voriconazole Effective Treatment Of Fungal Infections.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc., said that an Advisory Committee to the U.S. Food and Drug Administration (FDA) unanimously recommended approval of both oral and intravenous formulations of voriconazole for the treatment...

BioTransplant and Gambro Begin Distributing Eligix Cell Separation Devices in Europe.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- BioTransplant Inc. (BTRN) and Gambro BCT, a wholly owned subsidiary of Gambro AB (GAMBaST, GAMBbST) has begun distribution on BioTransplant's Eligix BCell-SC and TCell-DLI Cell Separation Systems in...

Phase III Study Under Way To Evaluate Fluorescence Cystoscopy.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Patient enrollment has begun for a European multicenter Phase III study to evaluate the safety and efficacy of PhotoCure ASA's Hexvix fluorescence cystoscopy for detection of bladder cancer. About 300...

Genta's Decoy Program Suppresses Key Cancer Genes In Breast and Ovarian Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Genta Inc. has announced the publication of two scientific papers that show an important pipeline drug downregulated key cancer genes and exerted potent preclinical antitumor activity in breast and...

Breakthrough Diagnostic Device Starts Clinical Studies.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- UltraTouch Corporation of Exton, Pennsylvania held a news conference in October (2001) to unveil the Palpagraph and announce the start of clinical studies using this revolutionary breast-mapping device....

CTLM System Installed In Instituto Nacional de Cancerologia.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Imaging Diagnostic Systems Inc. (IMDS) has installed its CTLM system into the Instituto Nacional de Cancerologia, the foremost cancer institute in Mexico. Founded in 1946, Instituto Nacional de...

Distance From Cancer Facility Affects Treatment Choices.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Women with early stage breast cancer who live 15 miles or more from a hospital offering radiotherapy are half as likely to choose lumpectomy, the breast conserving surgery, instead of mastectomy,...

Graveyard Shift, Light At Night Linked To Increased Risk.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Women who work the graveyard shift may face an up to 60% increased risk of breast cancer, according to a Fred Hutchinson Cancer Research Center study. Results of the study, the first...

Men Educated About Male Breast Cancer As Part Of Awareness Month.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- When you say the words breast cancer, most people do not think of men as victims. Unfortunately, men are also stricken with this terrible disease. Although breast cancer is much more common in...

Specialists Recommend Quicker Adoption, Wider Use Of New Technologies.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- The following statement was issued by the University of Southern California Health Sciences: Modern, cutting-edge technology and techniques such as mammography, breast ultrasound and minimally...

DOBI Medical Receives FDA Module Two Acceptance For ComfortScan.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has accepted the second module of DOBI Medical Systems' Pre-Market Approval (PMA) application for its Dynamic Optical Breast Imaging System, called...

New Chemotherapy Regimen Produces Long-Term, Disease-Free Survival.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Brief, intense cycles of high-dose chemotherapy produced long-term, disease-free survival in more than half of adults treated for Burkitt small non-cleaved lymphoma and Burkitt leukemia, researchers...

Targeting Hypoxia-Driven Genes May Be Valuable Treatment Strategy.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Duke University researchers have identified at least 10 hypoxia-regulated genes in human malignancies. Several of those genes drive angiogenesis, according...

FDA Fast Tracks Antigenics' Oncophage For Kidney Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has designated Oncophage, a cancer vaccine candidate developed by Antigenics, Inc. (AGEN), a Fast Track Product for the treatment of renal cell carcinoma. In...

Epstein-Barr Virus Not A Factor In American Cases Of Primary Liver Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Although recent reports have shown a link between Epstein-Barr virus (EBV) and hepatocellular carcinoma (HCC), or primary liver cancer, in the Japanese, studies...

T Cells Can Halt Development Of Skin Cancer, Yale Researchers Find.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- In a study published in Science, Yale researchers show that (gamma)-(delta) T cells, a special kind of white blood cell found in the skin, are critical in the defense against skin cancer development....

FDA Approves Use Of PREP Thin-Layer Slide Preparations With AutoPap System.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- TriPath Imaging Inc. has received approval from the U.S. Food and Drug Administration (FDA) to include the screening of AutoCyte PREP thin-layer slide preparations on the AutoPap Primary Screening...

Multikine Effective In HIV/HPV Infected Women.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- A presentation at the Annual Meeting of the International Society for Interferon and Cytokine Research in Cleveland, Ohio, by scientists from the Institute of Human Virology (IHV) and CEL-SCI suggests a...

Study Finds Pre-Op Pain Medication Not Given in 21% Of Procedures.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- A new study of medical practices in the performance of colonoscopy has found that preoperative pain medication is not administered in a disturbing 21% of these procedures - contributing to the negative...

OSU Scientists Study Soy And Tomato Diet For Prostrate Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Scientists are watching closely to see if men with prostate cancer are willing to make significant changes in their diet to help them fight prostate cancer. The research projects, under the...

Group Studies Estrogen Receptors And Cancer Prevention In Chronic Hepatitis C.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Estrogen, a hormone rarely mentioned without inciting controversy, may prevent liver cancer in patients chronically infected with hepatitis C virus (HCV). ...

Novel Anticancer Drugs Selectively Activate Apoptosis.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Myriad Genetics, Inc. has discovered a novel drug target for the treatment of a broad range of cancers and has initiated lead optimization with a series of compounds that selectively kill cancer cells....

Connection Among ATM Gene, Radiation, And Breast Cancer Sought.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Transgenomic, Inc. announced that the Virginia Mason-Research Center (VMRC) has upgraded to a WAVE System 3500HT for genetic analysis to identify mutations that cause breast cancer. Researchers at...

Cyclacel's CDK Inhibitor Candidate Meets Safety Objectives.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Cyclacel Limited, a United Kingdom-based cancer therapeutics company, has announced that CYC202, its lead CDK-inhibitor drug candidate, has completed Phase Ia evaluation in humans and is entering...

Scientists Prove That Protein Plays Role In Tumor Blood Supply.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- A genetic analysis of a protein believed to affect the formation of blood vessels has proved that Thrombospondin-1 does indeed regulate a tumor's ability to form the independent blood supply that...

Matrix Announces European Registration Plans For IntraDose.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Matrix Pharmaceutical Inc. will submit an application for the approval of IntraDose (cisplatin/epinephrine) Injectable Gel to the European Medicines Evaluation Agency (EMEA) through the EMEA's...

Survey Finds Women Have Many Misconceptions About Breast Cancer.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- In a recent nationwide survey, the American Cancer Society found that many women are misinformed when it comes to understanding breast cancer risk. According to the survey, nearly half of the...

Oakwood Laboratories Alleges With Patent Infringement For Lupron Depot.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Oakwood Laboratories, LLC, has filed suit in the United States District Court for the Northern District of Illinois alleging that TAP Pharmaceutical Products Inc. and its co-owners Abbott Laboratories...

Genmab And Immunex Collaborate To Develop Cancer Antibody.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Genmab A/S has entered a new collaborative agreement with Immunex Corp. to discover and develop a fully human antibody against a proprietary Immunex cancer target. Initially, this new antibody is...

Celgene Receives Orphan Drug Designation For Revimid.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Celgene Corp.'s Revimid, the company's lead immunomodulatory drug (IMiD), has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for multiple myeloma. Orphan drug...

Enrollment Completed For Phase II Trial Of LDP-341.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc. announced that it has completed enrollment of a Phase II clinical trial of LDP-341 (formerly PS-341) in patients with multiple myeloma. The accrual was completed ahead...

Raven Biotechnologies Delivers First MAb To ImmunoGen.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Raven Biotechnologies Inc. has delivered the first in a series of candidate monoclonal antibodies (MAbs) for evaluation by ImmunoGen Inc., an event that paves the way for potential future milestone...

Nasal Morphine Phase II Trial Initiated In Cancer Patients.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Company, Inc. announced in October (2001) that it has commenced enrollment in a Phase II clinical trial in the United States to evaluate the efficacy and safety of a novel, patent...

Implant Sciences Awarded Over $1,000,000 In Government Contracts.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Implant Sciences Corp. (IMX), which manufactures I-Plant Iodine-125 brachytherapy seeds for the treatment of prostate cancer has been awarded four government contracts and grants totaling approximately...

Ultrasound Contrast Agent Improve Detection.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. announced a landmark clinical study to take place at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, using Alliance's Imavist (AF0150) contrast agent with...

Endocare Expands Agreement To Distribute 15-Minute PSA Test To Urologists.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Endocare Inc. (ENDO), a developer of temperature-based treatments for prostate cancer and prostate obstruction, has signed a new expanded distribution agreement with privately held Carlsbad, CA-based...

AxCell Biosciences To Study Signal Transduction Families.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- AxCell Biosciences, a subsidiary of Cytogen Corp., has signed a Cooperative Research and Development Agreement with the National Cancer Institute (NCI) to research two major signal transduction families...

Genmab And Scancell Announce Cancer Antibody Product Collaboration.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Genmab A/S and Scancell Ltd., a privately held biotechnology company, will collaborate to create and develop fully human antibodies to cancer targets identified by Scancell. The first antibody product...

Soy Protein Prevents Skin Tumors From Developing In Mice.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- New research at the University of California, Berkeley, may add yet another boost to the healthy reputation of the humble soybean. A study published October 15, 2001, in the journal Cancer Research...

Alemtuzumab Successful In Clinical Trial.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany (SHR), announced that Campath (alemtuzumab), a humanized monoclonal antibody, was successfully tested in a clinical trial for the treatment of T-PLL (T-cell prolymphocytic...

Hologic Announces Launch Of Lorad E-Commerce Web Site.(Brief Article)
November 6, 2001... 2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Hologic Inc. (HOLX), a leading provider of specialized medical imaging equipment for women's health and general radiographic applications, has launched a service-oriented extranet site for its...

Vascular Hot Spots Could Define Prognosis In Gynecological Tumors.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Vascular 'hot spots' in the tumors of patients with uterine cervical cancer could provide significant information about patient prognosis. Scientists...

Type Of Treatment Determines Quality Of Life In First Year.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- The type of treatment patients receive for prostate cancer can impact their quality of life, particularly during the first year after treatment, according to a new study. Published in the November...

Novel Tumor Suppressor Maspin Prevents Invasion In Murine Mammary Growths.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The novel tumor suppressor maspin, an angiogenesis inhibitor, prevents cancer growth and spread in a murine model of mammary cancer. Researchers believe...

Blending Old Treatments With New Is Revolutionizing Care.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Blending old treatments and new ideas is transforming cancer care, says researchers speaking at ECCO 11 - the European Cancer Conference in Lisbon, Portugal. Scientists reported a number of...

Blood Transfusion Most Cost-Effective Option For Anemia Treatment.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Blood transfusion is the most cost-effective way to improve hemoglobin levels in cervical cancer patients undergoing radiation therapy, researchers in the...

Treatment May Reduce Disease Among Latinas, Other Ethnic Groups.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Reducing cervical cancer deaths among American Latinas will require more concerted educational programs and streamlined office visits, a University of California Irvine College of Medicine study has...

Elderly Patients Are Candidates For Stem Cell Transplantation.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Autologous stem cell transplantation can benefit elderly multiple myeloma patients, particularly when administered in tandem, researchers in the United States...

Simple Blood Test Highlights Complex Problems In Stomach Cancer Research.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A simple blood test may help to identify people at future risk from stomach cancer, the world's second most common fatal malignancy, a researcher reports. The test reveals if a patient has been...

Bio-Terrorism.Info Database and Weekly Report Launch Powered by NewsRx Artificial Intelligence Technology.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- NewsRx has leveraged its technology platform to create Bio-Terrorism.Info, a new database and weekly report. NewsRx is the leading provider of life science databases and daily and weekly health news....

Biomira Plans Interim Analysis Of Theratope Vaccine Data.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Merck KGaA and Biomira Inc. (BIOM) have announced that, following communications with the U.S. Food and Drug Administration (FDA), the companies will conduct a single interim analysis of data from...

Enrollment Begun In Large, World-Wide Trastuzumab Trial.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Enrollment into one of the most challenging breast cancer trials ever has begun from over 600 trial sites across the world. It is hoped that more than 3000 patients will be recruited to take part...

Erlotinib For Lung, Breast Cancers Starts Trials.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Studies testing the potential of leading drug candidate Tarceva (erlotinib) in treating two of the most common cancers, lung and breast, opened in October (2001) at a number of centers around the...

European Survey Exposes Poor Patient Awareness Of Treatment Options.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Patient awareness of potentially life-saving new breast cancer tests and treatments is woefully low among the majority of women with breast cancer across Europe, according to the results of a new...

Genetic Profiling May Play Greater Role In Identifying At-Risk Women.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A team of Cambridge University scientists have identified variants in six genes that may help to identify women at risk from breast cancer. They reported the findings at ECCO 11 - the European Cancer...

New Computer Tool Helps Forecast Outlook For Patients.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A powerful computer program to help doctors discuss early breast cancer treatment has been developed in the U.S. to help patients make more informed decisions about their future prospects. It was...

New Pathfinder Approach With Radioactive Tracer Reduces Surgical Trauma.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A revolutionary technique to treat breast cancer could safeguard patients from painful and disabling side effects of surgery, Professor Umberto Veronesi, scientific director of the European Institute...

Hologic Signs Agreement With Broadlane For Mammography System.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Hologic Inc. has been awarded an exclusive contract with Broadlane Inc., a provider of supply chain management services to the health care industry, to cover purchase and sale of Lorad mammographic...

'Double Suicide' Gene Therapy May Offer Safer Treatment For Prostrate Cancer.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A team of U.S. scientists has become one of the first in the world to use a novel form of double "suicide gene" therapy to treat prostate cancer - and it's done so with the help of a common cold virus....

Gene-Based Drug Uses Radiation-Regulated Gene Expression.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- GenVec, Inc. announced clinical development updates for one of its lead product candidates, TNFerade. TNFerade delivers the tumor necrosis factor alpha (TNF-alpha) gene directly to tumors using...

Lymphoma Patients Sought For Customized Therapy Trial.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Patients with low-grade B-cell non-Hodgkin lymphoma who have received no prior therapy are being recruited by 22 of the top cancer research sites across the United States and Canada. These sites are...

Genetic Identification Techniques Yield Clues To Cancer Susceptibility.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Human cancer tissue collections and mouse models are bringing scientists closer to identifying genetic markers of human cancer susceptibility that could improve cancer diagnostics, therapeutics, and...

Colorectal Cancer Patients Participate In Clinical Trial.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- An investigational vaccine for the treatment of colorectal cancer, one of the most common and deadly forms of cancer, has been cleared by the U.S. Food and Drug Administration (FDA) for clinical trial....

Dual Nature Of Oncogenes Could Provide Key To New Therapies.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Powerful systems and mechanisms exist within the human body to suppress the emergence of cancer, and it is only when those systems or mechanisms go wrong that we get the disease, according to Gerard I....

Reassurance From Negative Endoscopy Lowers Health Anxiety.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Anxious gastroenterology patients who receive the reassurance of a negative endoscopic exam show an immediate improvement in their health behavior, and these gains in well-being are maintained over...

Cancer Patients Need Regular Advice About What To Eat.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Misconceptions about what they should eat can result in people with cancer having the wrong kind of food and may decrease their physical functioning and compromise their quality of life, a specialist...

Marine Bacteria Looks Good As Source For Anticancer Drug.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Researchers at Scripps Institution of Oceanography at the University of California, San Diego (UCSD), have produced evidence that bacteria living inside a small marine animal may be the source of a new...

Black Raspberries Show Multiple Defenses In Thwarting Cancer.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A cup of black raspberries a day may help keep esophageal cancer at bay. Researchers found evidence in rats that black raspberries may both prevent the onset of esophageal cancer as well as inhibit...

Chiron Reports Third Quarter Earnings Boost Of 30 Cents Per Share.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) reported pro forma income from continuing operations of $58 million, or $0.30 per share, for the third quarter of 2001, as compared with $43 million, or $0.23 per share, reported...

Lack Of Trained Staff, Technical Support Increases Risk Of Cancer Progression.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Lack of staff trained to use new technology in cancer clinics could prolonging waiting time for radiation treatment and exacerbate the disease of patients urgently needing treatment, a professor in...

Photodynamic Therapy Deemed Effective Treatment.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- A therapy that activates light sensitive drugs represents a major advance in the treatment of head and neck cancer, a consultant surgeon reports. Known as Foscan photodynamic therapy (PDT), it is...

Genzyme Molecular Oncology Patents Newly Discovered Immunogens.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) has been issued a U.S. patent for the discovery of novel synthetic peptides and pharmaceutical compositions useful as therapeutic melanoma vaccines. Discovered by...

Viragen Confirms Anticancer Potential Of Chicken Egg Cells.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- Viragen Inc. and the Roslin Institute in Scotland have announced the successful production of the world's first humanized antibody using chicken cells. The humanized antibody, GD3, is designed for the...

Aplidin Shows Efficacy Against Numerous Cancer Types.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- The Spanish Health Ministry has given formal authorization for the Zeltia subsidiary, PharmaMar, to commence Phase II clinical trials of its compound Aplidin. Phase I trials, which involved 206...

Radioimmunotherapy Improves Clinical Responses In Chemotherapy Refractory Disease.(Brief Article)
November 13, 2001... 2001 NOV 13 - (NewsRx.com & NewsRx.net) -- An investigational radioimmunotherapy, Bexxar (tositumomab and iodine I 131 tositumomab), demonstrates more durable complete or partial clinical responses in patients with low-grade and transformed...